Challenges and novel opportunities of radiation therapy for brain metastases in non-small cell lung cancer
Keywords: 
Brain metastases
Non-small cell lung cancer
Stereotactic radiosurgery
Targeted therapies
Radionecrosis
Proton beam therapy
Animal models
Issue Date: 
2021
ISSN: 
2072-6694
Note: 
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/)
Citation: 
Jablonska, P. (Paola Anna); Bosch-Barrera, J. (Joaquim); Serrano-Tejero, D. (Diego); et al. "Challenges and novel opportunities of radiation therapy for brain metastases in non-small cell lung cancer". Cancers. 13 (9), 2021, 2141
Abstract
Lung cancer is the most common primary malignancy that tends to metastasize to the brain. Owing to improved survival of lung cancer patients, the prevalence of brain metastases is a matter of growing concern. Brain radiotherapy remains the mainstay in the management of metastatic CNS disease. However, new targeted therapies such as the tyrosine kinase or immune checkpoint inhibitors have demonstrated intracranial activity and promising tumor response rates. Here, we review the current and emerging therapeutical strategies for brain metastases from non-small cell lung cancer, both brain-directed and systemic, as well as the uncertainties that may arise from their combination.

Files in This Item:
Thumbnail
File
pdf.pdf
Description
Size
861.87 kB
Format
Adobe PDF


Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.